Stryker price target raised to $410 from $380 at Argus

Argus raised the firm’s price target on Stryker (SYK) to $410 from $380 and keeps a Buy rating on the shares after its Q3 earnings beat. The company has delivered strong operating results through solid execution and robust demand for its Mako Robotic Surgical system for orthopedic procedures, with Mako driving market share gains for Stryker, the analyst tells investors in a research note. The company is also strengthening its market position through M&A and new product launches, Argus added.